Jinhe Biotechnology CO., LTD. (002688.SZ)
CNY 7.18
(9.95%)
CNY 7.18
(9.95%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 497.77 Million CNY | 2.95% |
| 2022 | 441.76 Million CNY | 5.15% |
| 2021 | 420.13 Million CNY | 5.39% |
| 2020 | 398.65 Million CNY | 0.66% |
| 2019 | 396.03 Million CNY | 8.17% |
| 2018 | 366.11 Million CNY | 12.43% |
| 2017 | 325.63 Million CNY | 11.69% |
| 2016 | 291.56 Million CNY | 32.51% |
| 2015 | 220.02 Million CNY | 27.75% |
| 2014 | 172.23 Million CNY | 15.43% |
| 2013 | 149.2 Million CNY | 10.83% |
| 2012 | 134.63 Million CNY | 5.17% |
| 2011 | 128.01 Million CNY | 24.53% |
| 2010 | 102.79 Million CNY | 40.06% |
| 2009 | 73.39 Million CNY | 24.37% |
| 2008 | 59 Million CNY | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 103.77 Million CNY | -2.44% |
| 2024 Q3 | 136.04 Million CNY | 65.8% |
| 2024 Q1 | 106.36 Million CNY | -13.5% |
| 2023 Q2 | 102.83 Million CNY | 9.78% |
| 2023 Q1 | 93.67 Million CNY | -28.04% |
| 2023 FY | 454.78 Million CNY | 2.95% |
| 2023 Q4 | 122.96 Million CNY | -9.12% |
| 2023 Q3 | 135.3 Million CNY | 31.58% |
| 2022 Q4 | 130.18 Million CNY | 5.19% |
| 2022 FY | 441.76 Million CNY | 5.15% |
| 2022 Q3 | 123.75 Million CNY | 30.43% |
| 2022 Q2 | 94.88 Million CNY | 2.09% |
| 2022 Q1 | 92.93 Million CNY | -24.84% |
| 2021 FY | 420.13 Million CNY | 5.39% |
| 2021 Q2 | 77.88 Million CNY | -19.74% |
| 2021 Q3 | 121.56 Million CNY | 56.09% |
| 2021 Q1 | 97.03 Million CNY | -9.47% |
| 2021 Q4 | 123.64 Million CNY | 1.71% |
| 2020 Q2 | 90.46 Million CNY | 3.09% |
| 2020 Q1 | 87.75 Million CNY | -21.41% |
| 2020 Q4 | 107.18 Million CNY | -5.3% |
| 2020 FY | 398.65 Million CNY | 0.66% |
| 2020 Q3 | 113.19 Million CNY | 25.12% |
| 2019 Q2 | 89.3 Million CNY | -3.34% |
| 2019 FY | 396.03 Million CNY | 8.17% |
| 2019 Q4 | 111.66 Million CNY | 10.23% |
| 2019 Q3 | 101.3 Million CNY | 13.44% |
| 2019 Q1 | 92.38 Million CNY | -17.39% |
| 2018 Q2 | 83.77 Million CNY | 30.09% |
| 2018 Q1 | 64.4 Million CNY | -49.49% |
| 2018 Q4 | 111.82 Million CNY | 5.78% |
| 2018 FY | 366.11 Million CNY | 12.43% |
| 2018 Q3 | 105.71 Million CNY | 26.19% |
| 2017 Q4 | 127.5 Million CNY | 91.92% |
| 2017 Q2 | 70.5 Million CNY | 15.24% |
| 2017 FY | 325.63 Million CNY | 11.69% |
| 2017 Q1 | 61.18 Million CNY | -28.29% |
| 2017 Q3 | 66.43 Million CNY | -5.78% |
| 2016 Q4 | 85.32 Million CNY | -2.93% |
| 2016 FY | 291.56 Million CNY | 32.51% |
| 2016 Q3 | 87.9 Million CNY | 25.55% |
| 2016 Q2 | 70.01 Million CNY | 45.18% |
| 2016 Q1 | 48.22 Million CNY | -26.68% |
| 2015 Q2 | 45.31 Million CNY | 17.26% |
| 2015 Q1 | 38.64 Million CNY | -34.45% |
| 2015 FY | 220.02 Million CNY | 27.75% |
| 2015 Q4 | 65.77 Million CNY | -5.77% |
| 2015 Q3 | 69.8 Million CNY | 54.05% |
| 2014 Q4 | 58.95 Million CNY | 66.06% |
| 2014 FY | 172.23 Million CNY | 15.43% |
| 2014 Q2 | 41.52 Million CNY | 14.57% |
| 2014 Q1 | 36.24 Million CNY | -28.18% |
| 2014 Q3 | 35.5 Million CNY | -14.5% |
| 2013 Q3 | 37.21 Million CNY | 19.45% |
| 2013 Q4 | 50.46 Million CNY | 35.62% |
| 2013 FY | 149.2 Million CNY | 10.83% |
| 2013 Q1 | 30.34 Million CNY | -29.11% |
| 2013 Q2 | 31.15 Million CNY | 2.68% |
| 2012 Q2 | 27.07 Million CNY | 0.31% |
| 2012 Q4 | 42.8 Million CNY | 13.35% |
| 2012 Q1 | 26.99 Million CNY | -32.54% |
| 2012 Q3 | 37.76 Million CNY | 39.46% |
| 2012 FY | 134.63 Million CNY | 5.17% |
| 2011 Q4 | 40.01 Million CNY | 30.89% |
| 2011 Q3 | 30.56 Million CNY | 0.0% |
| 2011 FY | 128.01 Million CNY | 24.53% |
| 2010 FY | 102.79 Million CNY | 40.06% |
| 2009 FY | 73.39 Million CNY | 24.37% |
| 2008 FY | 59 Million CNY | 0.0% |